However, a retrospective study concluded that the efficacy of CTCs in diagnosing thyroid cancer is still limited considering the number of CTCs and the antibodies against thyroid peroxidase (ATPO) values in a cohort of thyroid tumor patients divided into malignant and benign groups [149]. Here, TPO is linked to thyroid cancer.